An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection

An Envelope Domain III–based Chimeric Antigen Produced in Pichia pastoris Elicits Neutralizing Antibodies Against All Four Dengue Virus Serotypes

(2018) Behzad Etemad et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model

(2018) Bruno Guy et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Dengue virus-like particles: construction and application

(2012) Weilong Shang et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine

(2012) Ryan L. Vander Veen et al.   VACCINE

Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization

(2012) William B. Messer et al.   PLoS Neglected Tropical Diseases

Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques

(2011) Jorge E. Osorio et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immune Response to Dengue Virus and Prospects for a Vaccine

(2011) Brian R. Murphy et al.   Annual Review of Immunology

Development of sanofi pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   Human vaccines & immunotherapeutics

Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection

(2011) S. A. Smith et al.   JOURNAL OF VIROLOGY

Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

(2011) Jorge E. Osorio et al.   VACCINE

Next generation dengue vaccines: A review of candidates in preclinical development

(2011) Julia Schmitz et al.   VACCINE

Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine

(2011) Anna P. Durbin et al.   VACCINE

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

(2011) Beth-Ann G. Coller et al.   VACCINE

Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development

(2011) Anna P. Durbin et al.   Viruses-Basel

The Human Antibody Response to Dengue Virus Infection

(2011) Wahala M. P. B. Wahala et al.   Viruses-Basel

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

(2011) Anna P. Durbin et al.   PLoS Neglected Tropical Diseases

In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection

(2011) Ruklanthi de Alwis et al.   PLoS Neglected Tropical Diseases

Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced by Spodoptera frugiperda Cells for Use as Vaccine and Diagnostic Antigens

(2010) M. Kuwahara et al.   Clinical and Vaccine Immunology

Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3

(2010) James D. Brien et al.   JOURNAL OF VIROLOGY

An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection

(2010) C. M. Midgley et al.   JOURNAL OF VIROLOGY

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

(2010) S. Sukupolvi-Petty et al.   JOURNAL OF VIROLOGY

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization

(2010) Daniel R. Tonkin et al.   VACCINE

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial

(2010) Charmagne G. Beckett et al.   VACCINE

Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape

(2010) Gregory D. Gromowski et al.   VIROLOGY

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses

(2010) Wahala M. P. B. Wahala et al.   PLoS Pathogens

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

(2010) Bimmi Shrestha et al.   PLoS Pathogens

Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease

(2009) Scott C. Weaver et al.   INFECTION GENETICS AND EVOLUTION

Recent progress on sanofi pasteur's dengue vaccine candidate

(2009) Jean Lang   JOURNAL OF CLINICAL VIROLOGY

Immunogenicity of sanofi pasteur tetravalent dengue vaccine

(2009) Bruno Guy   JOURNAL OF CLINICAL VIROLOGY

Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E

(2009) S. Kiermayr et al.   JOURNAL OF VIROLOGY

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens

(2009) Wayne D. Crill et al.   PLoS One

An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity

(2009) Saima Khanam et al.   VACCINE

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers

(2009) David I. Bernstein et al.   VACCINE

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice

(2009) Iris Valdés et al.   VIROLOGY

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

(2009) W.M.P.B. Wahala et al.   VIROLOGY

Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties

(2009) Wenquan Liu et al.   VIRUS GENES

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

(2008) L BERNARDO et al.   ANTIVIRAL RESEARCH

Neutralizing antibody response variation against dengue 3 strains

(2008) Mayling Alvarez et al.   JOURNAL OF MEDICAL VIROLOGY

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

(2008) K. Raviprakash et al.   JOURNAL OF VIROLOGY

An Alphavirus Replicon-Based Human Metapneumovirus Vaccine Is Immunogenic and Protective in Mice and Cotton Rats

(2008) H. Mok et al.   JOURNAL OF VIROLOGY

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

(2008) C.-Y. Lai et al.   JOURNAL OF VIROLOGY

Geographic Expansion of Dengue: The Impact of International Travel

(2008) Annelies Wilder-Smith et al.   MEDICAL CLINICS OF NORTH AMERICA

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

(2008) Chih-Hsiang Leng et al.   MICROBES AND INFECTION

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

(2008) Shee-Mei Lok et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation

(2008) L. Li et al.   SCIENCE